BIAL is an innovative international pharmaceutical company committed to improve human health and quality of life for people from all over the world.
Dedicated to discovering, developing and commercializing medicines, BIAL is strongly dedicated to therapeutic innovation, consistently investing more than 20% of its annual revenue in Research and Development (R&D), where the company established an ambitious programme. The core R&D areas of BIAL are neurosciences and cardiovascular.
The company’s headquarters are located in Portugal and BIAL has been strengthening its international presence based in its own innovative medicines and in a consistent partnering program. It has affiliates in several European countries - Spain, Germany, United Kingdom, Italy and Switzerland -, in the US and in emergent markets as Mozambique, Angola, Ivory Coast and Panama. In the US, BIAL has established BIAL Biotech Investments Inc. (BIAL Biotech). BIAL is making a real difference to the lives of people all over the world inspired by its strong motivation: Keeping life in mind.
Additional information can be found here: www.bial.com
BIAL Foundation takes responsibility for its website contents. By clicking “continue” below, you will be taken to an external website, beyond our responsibility.